Stiefel J, Flower A, Botwinick M, Ford M, Foti A, Gandhi M, Slovin J, Smilow E, Bowers A, Karpel H, Schwartz L, Fraint E, Gennarini L, Gardner S, Raetz E, Shah N, Chen J, Krajewski J, Hijiya N, Satwani P, Hochberg J, Mauguen A, Curran K, Sulis M. Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL. Blood 2022, 140: 7763-7765. DOI: 10.1182/blood-2022-160272.Peer-Reviewed Original Research